Application no. and date | 08748334.3 (espacenet) (Federated) (European Patent Register), 20080521 | Patent/reg. no. and date | DK/EP 2150613, 20161019 | Publication date | 20100210 | Priority no. and date | US 939255 P, 20070521 | EP pub. no. and date |
EP 2150613 20100210 | Effective date | | Applicant/owner | Oncolytics Biotech, Inc., Suite 210, 1167 Kensington Crescent N.W.
Calgary, Alberta T2N 1X7, CA | Applicant ref. no. | P018999EPDK1 JOS/Ve | Inventor | Coffey, Matthew C., 2231 Bowness Road, N.W.
Calgary,
Alberta T2N 3L4, CA, THOMPSON, Bradley G., 1775 - 7th Avenue, N.W.
Calgary, Ontario T2N 0Z5, CA | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 35/76 (2015.01) , A61P 35/00 (2006.01) , C07K 14/14 (2006.01) , C12N 15/46 (2006.01) , C12N 15/86 (2006.01) , C12N 7/01 (2006.01) | Title | MUTANT REOVIRA OG FREMGANGSMÅDER TIL DERES FREMSTILLING OG ANVENDELSE | Int. application no. | CA2008000964 | Int. publication no. | WO2008141448 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|